about
Evolving Insights on Metabolism, Autophagy, and Epigenetics in Liver MyofibroblastsUtilization of animal models to investigate non-alcoholic steatohepatitis-associated hepatocellular carcinomaNonalcoholic fatty liver disease as a multi-systemic diseaseTreatment of patients with type 2 diabetes and non-alcoholic fatty liver disease: current approaches and future directionsType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightMicroRNAs in Nonalcoholic Fatty Liver DiseaseTreatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight LossNonalcoholic steatohepatitis: emerging targeted therapies to optimize treatment optionsHepatocellular carcinoma in patients with non-alcoholic fatty liver diseaseHepatocellular carcinoma: a reviewThe Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver DiseaseEndocrine-disrupting chemicals and fatty liver disease.Non-alcoholic Fatty Liver Disease in South Asians: A Review of the LiteratureNonalcoholic steatohepatitis-related hepatocellular carcinoma: is there a role for the androgen receptor pathway?Genetic predisposition in nonalcoholic fatty liver disease.Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.Treatment of nonalcoholic fatty liver disease: role of AMPK.Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis.Editorial: Age and Non-Invasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease: Time to Adjust the Clock?Hepatocytes release ceramide-enriched pro-inflammatory extracellular vesicles in an IRE1α-dependent manner.A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains.Fatty liver disease determines the progression of coronary artery calcification in a metabolically healthy obese population.Total fecal microbiota transplantation alleviates high-fat diet-induced steatohepatitis in mice via beneficial regulation of gut microbiota.Hepatic estrogen receptor α is critical for regulation of gluconeogenesis and lipid metabolism in malesCocaine Use and Liver Disease are Associated with All-Cause Mortality in the Miami Adult Studies in HIV (MASH) Cohort.Early Intervention With Live Donor Liver Transplantation Reduces Resource Utilization in NASH: The Toronto ExperienceTreatment of Nonalcoholic Fatty Liver Disease (NAFLD) in patients with Type 2 Diabetes Mellitus.Exosomes derived from palmitic acid-treated hepatocytes induce fibrotic activation of hepatic stellate cellsOver-expressing the soluble gp130-Fc does not ameliorate methionine and choline deficient diet-induced non alcoholic steatohepatitis in mice.Prevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis.Prevalence and predictors of irritable bowel syndrome in patients with morbid obesity: a cross-sectional studySilencing of FABP1 ameliorates hepatic steatosis, inflammation, and oxidative stress in mice with nonalcoholic fatty liver disease.Asymptomatic Meibomian Gland Dysfunction and Cardiovascular Disease Risk Factors in a Middle-Aged Population in Taiwan - A Cross-sectional Analysis.Influence of Fatty Liver on the Severity and Clinical Outcome in Acute PancreatitisAssociation between Dietary Vitamin C Intake and Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study among Middle-Aged and Older Adults.Ipragliflozin Improves Hepatic Steatosis in Obese Mice and Liver Dysfunction in Type 2 Diabetic Patients Irrespective of Body Weight Reduction.Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in miceDiscrimination of Nonalcoholic Steatohepatitis Using Transient Elastography in Patients with Nonalcoholic Fatty Liver Disease.
P2860
Q26745566-314AA288-171A-4DE1-A2CD-4190860E1903Q26748807-0FFD9B5D-06B4-4C1B-9B2C-F74C525BED12Q26749290-A6F56926-7178-4F7F-8CF8-DE1882DE11F6Q26751258-70877189-0C66-4801-8956-6A408CD62997Q26752583-A36C1B1E-F1C1-4601-920B-DDF1BF3BB211Q26774294-22D6117C-B917-4EF4-83B9-57AD4AF18ED9Q26775632-EF9CF7A1-2C9D-4257-9D90-5B5963619581Q26796448-9B9F020D-5E98-46D1-A148-D1EEF461385BQ28066100-83FB69F9-04DA-433F-B3AC-98B9D3173F5DQ28069290-D0A14870-60F5-4FD1-A1EE-BC1FB6B79EE5Q28078754-F89CA194-72B9-422B-92BB-BE1E51007D03Q30234414-D5540656-1DE2-44F4-889E-128C2C9F4E4BQ30234443-3E49F616-5FB4-4B04-8B68-5238F0AD7ADEQ30234736-7ADB073E-3241-45C7-B46D-EE14F3D3387DQ30235398-5FF98A26-BA52-4FF0-A97C-804CDC0BCE2CQ30238749-A717FB6A-83AB-47DC-BF71-BB1BBD7374F1Q30248230-FF34A190-5B0D-4A7F-B9B2-D3D2D31EB322Q30248535-834E840F-81BB-4C25-8F13-BA3C0A2E02A0Q30252463-F7465416-FF99-423A-9FE4-D3E6811AD201Q30701525-2C75C69B-8B9C-48B4-B9B7-A1238537C0C1Q31171499-D3DDF618-F2D7-4E3A-8022-72F6B93B9ED5Q33574490-B3629BC9-0A1A-4658-8212-EFDEE84BED27Q33685907-D128FCC0-F7B3-4F58-9827-1CD6EF998262Q33687175-A1FEE874-E82C-4A94-BA6A-858A499D0117Q33712066-AC60B597-D0EF-45D8-836B-31FE9789740BQ33779040-0E7CCFE3-1FFD-47AB-B7CC-D7D5B8B4E6CCQ33802278-81F8EB26-723A-4342-9946-617744A9F0F7Q33807881-823DFCCE-A94B-4E38-9370-03426F9FC60BQ33817373-538888DA-6E1C-470B-BFBD-4CD3A6C16728Q33832177-5A7F391C-3BBC-4CB7-AC60-2ADEA7028D77Q33840930-ACE186A6-9F91-40C1-9EB5-4A28A0436929Q33844302-5A2D757B-8A93-4A44-8D73-6F9D5C342DDBQ33851122-7EBD2139-7B01-4753-964A-D5BB2F4F2152Q33862990-52431B8B-DC12-4798-99AB-1C512174E14EQ33890341-09FDBDC1-DEAA-41B1-AF40-D932F20360AEQ35842213-EC479AAB-581E-40D4-B125-36B3D2B9CBFBQ35908245-DA5EF33E-CB3F-4151-9926-04813B5D5EC8Q35957448-DFAC008F-67E4-4E7D-A21E-902559001206Q35996623-2607EC61-FF39-478A-817A-D1272D329728Q36047930-484094AB-1D1E-4E17-8749-A02317E95FED
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Nonalcoholic fatty liver disease: a systematic review
@ast
Nonalcoholic fatty liver disease: a systematic review
@en
Nonalcoholic fatty liver disease: a systematic review
@nl
type
label
Nonalcoholic fatty liver disease: a systematic review
@ast
Nonalcoholic fatty liver disease: a systematic review
@en
Nonalcoholic fatty liver disease: a systematic review
@nl
prefLabel
Nonalcoholic fatty liver disease: a systematic review
@ast
Nonalcoholic fatty liver disease: a systematic review
@en
Nonalcoholic fatty liver disease: a systematic review
@nl
P3181
P356
P1476
Nonalcoholic fatty liver disease: a systematic review
@en
P2093
Mary E Rinella
P304
P3181
P356
10.1001/JAMA.2015.5370
P407
P577
2015-06-09T00:00:00Z